Advertisement

Effects of Cocaine and Other Drugs of Abuse on Immune Function

  • Robert M. Donahoe
  • Arthur Falek
  • John J. Madden
  • Janet K. A. Nicholson
  • Peter Bokos
  • Karl Gallegos
  • Richard Veit
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 288)

Abstract

Approximately 19 years ago, Falek et al. (1) reported that heroin addicts frequently exhibit abnormally high levels of cytogenetic damage in their T-lymphocytes after mitogenic stimulation in vitro with the plant lectin, phytohemag-glutinin. Later, Madden et al. (2) showed that this damage was probably due to altered DNA-repair capacity of lymphocytes. Less obvious, perhaps, than the genetic implications of these findings were their immunological implications, which, in fact, were significant.

Keywords

Opiate Receptor Cocaine Abuse Heroin Addict Heroin Abuse Opiate Addict 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A. Falek, R. B. Jordan, B. S. King, P. J. Arnold, and W. D. Skelton, Human and opiates,Arch.Gen.Psychiatry 27:511 (1972).PubMedCrossRefGoogle Scholar
  2. 2.
    J. J. Madden, A. Falek, D. A. Shafer, and J. H. Glick, Effects of opiates and factors on DNA repair synthesis in human leukocytes, Proc.Nat.Acad. Sci. 76:5769(1979).PubMedCrossRefGoogle Scholar
  3. 3.
    J. D. Sapira, J. C. Ball, and H. Penn, Causes of death among institutionalized addicts, J.Chronic. Dis. 22:733 (1970)PubMedCrossRefGoogle Scholar
  4. 4.
    D. B. Louria, Infectious complications of nonalcoholic drug abuse, Annu.Rev Med. 25:219 (1974)PubMedCrossRefGoogle Scholar
  5. 5.
    S. W. Brown, B. Stimmel, R. N. Taub, S. Kochwa, and R. E. Rosenfeld,Immunological dysfunction in heroin addicts,Arch.Intern.Med. 134:1001 (1974).PubMedCrossRefGoogle Scholar
  6. 6.
    C. Archard, H. Benard, and C. Gagneux, Action de la morphine sur lesproprietes leukocytaires: leuka-diagnostic du morphinisme,BullMem. Soc.MedHosp.Paris.28,958,1909Google Scholar
  7. 7.
    I. H. Pierce and O. H. Plant, Studies in chronic morphine poisoning in dogs.Changes in blood cells and hemoglobin during drug addiction and withdrawal, J.Pharmacol.Exp.Ther. 33:359 (1928).Google Scholar
  8. 8.
    J. Wybran, T. Appelboom, J. P. Famaey, and A. Govaerts, Suggestive evidence, receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes, J.Immunol. 123:1086 (1979).Google Scholar
  9. 9.
    R. J. McDonoughJ. J. MaddenA. FalekD. A. ShaferM. PlineD. Gordon,P. Bokos, J. C. Kuehnle, and J. Mendelson, Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence of opiate receptor sites on T lymphocytes, J.Immunol. 125:2539 (1980).PubMedGoogle Scholar
  10. 10.
    R. M. Donahoe, J. K. A. Nicholson, J. J. Madden, F. Donahoe, D. A. Shafer,,D. Gordon, P. Bokos, and A. Falek, Coordinate and independent effects of heroin, cocaine and alcohol abuse on T-cell E-rosette formation and antigenic marker modulation,Clin.Immunol.Immunopathol. 41:254 (1986).PubMedCrossRefGoogle Scholar
  11. 11.
    R. M. DonahoeJ. J. MaddenF. HollingsworthD. A. ShaferA. Falek,A. Nicholson, and P. Bokos, Immunomodulation by behaviorally active drugs provides a paradigm for connecting AIDS-like processes and psycho-neuroimmunology, in: “Neuroimmunomodulation: Proceedings of the First International Workshop on Neuroimmunomodulation,” N. H. Spector, ed., International Working Group on Neuroimmunomodulation, Bethesda (1985).Google Scholar
  12. 12.
    J. Layon, A. Idris, M. Warzynski, R. Shere, D. Brauner, O. Patch, D.McCulley, and P. Orris, Altered T-lymphocyte subsets in hospitalized intravenous drug abusers,Arch.Intern.Med. 133:1376 (1984).CrossRefGoogle Scholar
  13. 13.
    D. C. Des Jarlais, S. R. Friedman, and W. Hopkins, Risk reduction for the acquired immunodeficiency disease syndrome among intravenous drug users,Ann.Intern.Med. 103:755 (1985).Google Scholar
  14. 14.
    R. M. Donahoe and A. F. Falek, Neuroimmunomodulation by opiates and drugs of abuse: Relationship to HIV infection and AIDS.Adv.Bioch.Psychopharmacol. 44: 145 (1988).Google Scholar
  15. 15.
    R. M. Donahoe, C. Bueso-Ramos, F. Donahoe, J. J. Madden, A. Falek, J. K.,A. Nicholson, and P. Bokos, Mechanistic implications of the findings that opiates and other drugs of abuse moderate T-cell surface receptors and antigenic markers,Ann. NY.Acad. Sci. 496:711 (1987).PubMedCrossRefGoogle Scholar
  16. 16.
    R. M. Donahoe, C. Bueso-Ramos, A. Falek, H. Mc-Clure, and J. K. A.Nicholson, Comparative effects of morphine on leukocytic antigenic markers of monkeys and humans, J.Neurosci.Res. 19:157 (1988).PubMedCrossRefGoogle Scholar
  17. 17.
    J. Wybran and E. Dupont, The active T rosette: An early marker for T-cell,Ann.Immunol. 133D:211 (1982).Google Scholar
  18. 18.
    W. H. West, G. B. Cannon, H. D. Kay, G. D. Bonnard, and R. B. Herberman,, Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: Characterization of effector cells, J.Immunol. 118:355 (1977).PubMedGoogle Scholar
  19. 19.
    J. Van Wauwe and J. Gossens, E-rosette formation at 37°C: Analysis with OKT antibodies, Cell.Immunol. 68:181 (1982).PubMedCrossRefGoogle Scholar
  20. 20.
    R. M. Donahoe, J. J. Madden, F. Hollingsworth, D. A. Shafer, and A. Falek, ,Morphine depression of T cell E-rosetting: Definition of the process,Fed. Proc. 44:95 (1985).PubMedGoogle Scholar
  21. 21.
    E. S. Watson, J. C. Murphy, H. L. El Sohly, M. A. El Sohly, and C. E. Turner,,Effects of the administration of coca alkaloids on the primary immune responses of mice: Interaction with delta-9-tetrahydrocannabinol and ethanol,Toxicol.Appl.Pharmacol. 71:1 (1983).PubMedCrossRefGoogle Scholar
  22. 22.
    T. W. Klein, C. A. Newton, and H. Friedman, Suppression of human and mouse lymphocyte proliferation by cocaine,Adv.Biochem.Pharmacol. 44:139. (1988).Google Scholar
  23. 23.
    C. Van Dyke, A. Stein, R. Jones, A. Chuntharapai, and W. Seaman, Cocaine natural increases killer cell activity, J.Clin.Invest. 77:1387 (1986).PubMedCrossRefGoogle Scholar
  24. 24.
    J. N. Merishi and I. H. Mills, Opiate receptors on lymphocytes and platelets in manClin.Immunol.Immunopathol. 27:240 (1983).CrossRefGoogle Scholar
  25. 25.
    N. E. S. Sibinga and A. Goldstein, Opioid peptides and opioid receptors in cell of the immune system,Ann.Rev.Immunol. 6:219 (1988).CrossRefGoogle Scholar
  26. 26.
    J. J. Madden, R. M. Donahoe, J. Zwemer-Collins, D. Shafer, and A. Falek,Binding of naloxone to human T lymphocytes,Biochem.Pharmacol. 36:4103 (1987).PubMedCrossRefGoogle Scholar
  27. 27.
    A. L. Lopker, G. Abood, W. Hoss, and F. J. Lionetti, Stereospecific muscarinic and opiate receptors in human phagocytic leukocytes,Bio chem.Pharmacol. 29:1361 (1980).CrossRefGoogle Scholar
  28. 28.
    D. J. J. Carr, B. R. DeCosta, C.-H. Kim, A. E. Jacobson, V. Guarcello, K. C.Rice, and J. E. Blalock, Opioid receptors on cells of the immune system: evidence for delta-and kappa-classes, J.Endocrinology 122:161 (1989).CrossRefGoogle Scholar
  29. 29.
    R. H. Kerman and W. P. Geis, Total and active T-cell dynamics in renal recipients,Surgery 79:398 (1976).PubMedGoogle Scholar
  30. 30.
    B. E. Bierer, A. Peterson, J. C. Gorga, S. H. Herrmann, and S. J. Burakoff,Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor, J. Exp.Med. 168:1145 (1988).PubMedCrossRefGoogle Scholar
  31. 31.
    A. G. Dalgleish, P. C. L. Beverley, P. R. Clapham, D. H. Crawford, M. F.Greaves, and R. A. Weiss, The CDA (T4) antigen is an essential component of the receptor for AIDS retrovirus,Nature 312:763 (1986).CrossRefGoogle Scholar
  32. 32.
    D. Klatzman, E. Champagne, S. Chamerets, J. Greust, D. Guetard, T.Hercend, J.-C. Gluckmon, and L. Montagnier, T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV,Nature 312:767 (1986).CrossRefGoogle Scholar
  33. 33.
    R. E. Chaisson, P. Bacchetti, D. Osmond, B. Brodie, M. A. Sande, and A. R.Moss, Cocaine use and HIV infection in intravenous drug users in San Francisco, J. Am.Med.Assoc. 261:561 (1989).CrossRefGoogle Scholar
  34. 34.
    A Bernard, C. Gelin, B. Raynal, D. Pham, C. Gosse, and L. Boumsell, Phenomenon of human T cells rosetting with monoclonal antibodies. “Modulation” of a partially hidden epitope determining the conditions of interaction between T cells and erythrocytes, J.Exp.Med. 155:1317 (1982).PubMedCrossRefGoogle Scholar
  35. 35.
    R. Fantozzi, D. Mullikin-Kilpatrick, and A.J. Blume, Irreversible inactivation of opiate receptors in the neuroblastoma X glioma hybrid NG 108–15 by chlornaltrexamine,Mol.Pharmacol. 20:146 (1981).Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Robert M. Donahoe
    • 1
    • 2
  • Arthur Falek
    • 2
  • John J. Madden
    • 2
  • Janet K. A. Nicholson
    • 3
  • Peter Bokos
    • 4
  • Karl Gallegos
    • 5
  • Richard Veit
    • 5
  1. 1.Laboratory of PsychoimmunologyEmory University, GMHIAtlantaUSA
  2. 2.Department of PsychiatryEmory UniversityUSA
  3. 3.Division of Host FactorsCenters for Disease ControlAtlantaUSA
  4. 4.Interventions, IncorporatedChicagoUSA
  5. 5.Georgia Alcohol and Drug AssociatesAtlantaUSA

Personalised recommendations